Neurosurgical patients are at great risk for venous thromboembolism. Thromboprophylaxis
is either with unfractionated heparin or low molecular weight heparin (LMWH). In …

Neurosurgical patients are at significant risk of thromboembolic complications. A survey of
58 consultant neurosurgeons in United Kingdom confirmed that 84.5% regularly used some …

BACKGROUND: Randomized clinical trials (RCTs) have usually supported using heparin
prophylaxis against venous thromboembolism (VTE) in patients undergoing cranial …

¶ Background. Despite the high risk of venous thromboembolic events (VTE) in neuro-
surgical patients, heparin prophylaxis has not been routinely established due to concern …

Background Venous thromboembolism is a common, life-threatening complication in
neurosurgery, but prophylaxis with anticoagulant agents has not gained wide acceptance …

PURPOSE: Venous thromboembolism (VTE) is an important complication of neurosurgery.
Current guidelines recommend pharmacologic prophylaxis in this setting with either …

Perioperative anticoagulant prophylaxis for postoperative venous thromboembolism (VTE)
in neurosurgical patients has not gained wide acceptance due to the fear of intracranial …

Background: Several studies have confirmed the role of prophylactic low-molecular-weight
heparin (LMWH) for venous thromboembolism (VTE) in neurosurgery; however, a paucity of …

Structured abstract Objective To explore the difference in post-operative DVT, PE, and ICH
complications following administration of prophylactic UFH or enoxaparin in patients …

Methods: We searched the medical literature to identify prospective trials reporting on VTE
prevention (either mechanical or pharmacologic). The rates of VTE and bleeding were our …